Leukemia Research Foundation

About Leukemia Research Foundation

The Leukemia Research Foundation’s most visible pattern is its steady stream of $150,000 New Investigator Research Grants, directed to early-stage investigators working on leukemia research. In the latest grant list, that support reached institutions such as City of Hope Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, and the University of Pittsburgh Cancer Institute. The foundation’s funding is built around investigator-initiated research, with grants aimed at improving understanding of leukemia and accelerating new treatments. Its mission centers on leukemia research across major disease types, including AML, ALL, CML, and CLL, while also extending to myelodysplastic syndromes in its new investigator program. The organization also describes patient-centered support and education as part of its broader purpose, including clinical trial education and participation. Recent awards show a clear emphasis on research capacity building: grants have gone to new independent investigators, junior faculty, and early-career researchers at major medical schools, cancer centers, and hospitals across the United States. The grant record points to a funder that uses project-based support to advance laboratory and clinical work rather than individual aid or program-related investing.

What Leukemia Research Foundation Funds

The foundation’s clearest cause area is leukemia research. It awarded $150,000 to The University of Texas MD Anderson for a New Investigator Research Grant, and another $150,000 to Weill Medical College of Cornell University for the same program. Those awards align with its stated goal of funding investigator-initiated projects that deepen understanding of leukemia and support new treatments. A second thread is early-career research support. Grants to Massachusetts General Hospital and Washington University School of Medicine in St Louis each carried $150,000 New Investigator Research Grants, showing a focus on helping new independent investigators build research programs. The foundation also supports work touching myelodysplastic syndromes through the New Investigator Research Grant Program. Its broader mission includes patient and family support services and clinical trial education, which sit alongside the research portfolio as part of the organization’s stated purpose.

How Leukemia Research Foundation Gives